ORANGE BELGIUM (OBEL.BR) Fundamental Analysis & Valuation

EBR:OBEL • BE0003735496

19.8 EUR
0 (0%)
Last: Mar 3, 2026, 07:00 PM

This OBEL.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

OBEL gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 6 industry peers in the Wireless Telecommunication Services industry. While OBEL is still in line with the averages on profitability rating, there are concerns on its financial health. OBEL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. OBEL.BR Profitability Analysis

1.1 Basic Checks

  • OBEL had positive earnings in the past year.
  • OBEL had a positive operating cash flow in the past year.
  • OBEL had positive earnings in each of the past 5 years.
  • In the past 5 years OBEL always reported a positive cash flow from operatings.
OBEL.BR Yearly Net Income VS EBIT VS OCF VS FCFOBEL.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M -200M 400M

1.2 Ratios

  • OBEL's Return On Assets of 0.93% is in line compared to the rest of the industry. OBEL outperforms 50.00% of its industry peers.
  • With a decent Return On Equity value of 3.88%, OBEL is doing good in the industry, outperforming 66.67% of the companies in the same industry.
  • OBEL has a Return On Invested Capital of 3.63%. This is in the better half of the industry: OBEL outperforms 66.67% of its industry peers.
Industry RankSector Rank
ROA 0.93%
ROE 3.88%
ROIC 3.64%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OBEL.BR Yearly ROA, ROE, ROICOBEL.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • OBEL's Profit Margin of 1.89% is on the low side compared to the rest of the industry. OBEL is outperformed by 66.67% of its industry peers.
  • OBEL's Profit Margin has declined in the last couple of years.
  • OBEL has a Operating Margin (7.62%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of OBEL has grown nicely.
  • OBEL has a better Gross Margin (68.11%) than 100.00% of its industry peers.
  • In the last couple of years the Gross Margin of OBEL has grown nicely.
Industry RankSector Rank
OM 7.62%
PM (TTM) 1.89%
GM 68.11%
OM growth 3Y-5.83%
OM growth 5Y6.31%
PM growth 3Y-20.46%
PM growth 5Y-12.52%
GM growth 3Y4.66%
GM growth 5Y2.94%
OBEL.BR Yearly Profit, Operating, Gross MarginsOBEL.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

0

2. OBEL.BR Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), OBEL is destroying value.
  • There is no outstanding debt for OBEL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
OBEL.BR Yearly Shares OutstandingOBEL.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
OBEL.BR Yearly Total Debt VS Total AssetsOBEL.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • Based on the Altman-Z score of 0.97, we must say that OBEL is in the distress zone and has some risk of bankruptcy.
  • OBEL has a Altman-Z score of 0.97. This is in the lower half of the industry: OBEL underperforms 66.67% of its industry peers.
  • The Debt to FCF ratio of OBEL is 23.91, which is on the high side as it means it would take OBEL, 23.91 years of fcf income to pay off all of its debts.
  • OBEL's Debt to FCF ratio of 23.91 is on the low side compared to the rest of the industry. OBEL is outperformed by 83.33% of its industry peers.
  • OBEL has a Debt/Equity ratio of 1.92. This is a high value indicating a heavy dependency on external financing.
  • The Debt to Equity ratio of OBEL (1.92) is worse than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF 23.91
Altman-Z 0.97
ROIC/WACC0.5
WACC7.22%
OBEL.BR Yearly LT Debt VS Equity VS FCFOBEL.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • OBEL has a Current Ratio of 0.49. This is a bad value and indicates that OBEL is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.49, OBEL is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.46 indicates that OBEL may have some problems paying its short term obligations.
  • OBEL's Quick ratio of 0.46 is on the low side compared to the rest of the industry. OBEL is outperformed by 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.49
Quick Ratio 0.46
OBEL.BR Yearly Current Assets VS Current LiabilitesOBEL.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. OBEL.BR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 75.72% over the past year.
  • OBEL shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.42% yearly.
  • OBEL shows a strong growth in Revenue. In the last year, the Revenue has grown by 46.76%.
  • Measured over the past years, OBEL shows a quite strong growth in Revenue. The Revenue has been growing by 8.35% on average per year.
EPS 1Y (TTM)75.72%
EPS 3Y-14.2%
EPS 5Y-7.42%
EPS Q2Q%9.76%
Revenue 1Y (TTM)46.76%
Revenue growth 3Y12.17%
Revenue growth 5Y8.35%
Sales Q2Q%93.22%

3.2 Future

  • Based on estimates for the next years, OBEL will show a very negative growth in Earnings Per Share. The EPS will decrease by -10.95% on average per year.
  • OBEL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.71% yearly.
EPS Next Y-56.38%
EPS Next 2Y-47.41%
EPS Next 3Y-24.56%
EPS Next 5Y-10.95%
Revenue Next Year1.24%
Revenue Next 2Y0.75%
Revenue Next 3Y3.52%
Revenue Next 5Y2.71%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
OBEL.BR Yearly Revenue VS EstimatesOBEL.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B
OBEL.BR Yearly EPS VS EstimatesOBEL.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.2 0.4 0.6 0.8 1

3

4. OBEL.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 30.46, OBEL can be considered very expensive at the moment.
  • OBEL's Price/Earnings ratio is a bit more expensive when compared to the industry. OBEL is more expensive than 66.67% of the companies in the same industry.
  • OBEL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.83, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 94.69 indicates a quite expensive valuation of OBEL.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of OBEL indicates a slightly more expensive valuation: OBEL is more expensive than 66.67% of the companies listed in the same industry.
  • OBEL is valuated expensively when we compare the Price/Forward Earnings ratio to 24.95, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 30.46
Fwd PE 94.69
OBEL.BR Price Earnings VS Forward Price EarningsOBEL.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, OBEL is valued cheaper than 83.33% of the companies in the same industry.
  • 66.67% of the companies in the same industry are more expensive than OBEL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 15.18
EV/EBITDA 5.45
OBEL.BR Per share dataOBEL.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

  • The decent profitability rating of OBEL may justify a higher PE ratio.
  • OBEL's earnings are expected to decrease with -24.56% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-47.41%
EPS Next 3Y-24.56%

0

5. OBEL.BR Dividend Analysis

5.1 Amount

  • OBEL does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

OBEL.BR Fundamentals: All Metrics, Ratios and Statistics

ORANGE BELGIUM

EBR:OBEL (3/3/2026, 7:00:00 PM)

19.8

0 (0%)

Chartmill FA Rating
GICS IndustryGroupTelecommunication Services
GICS IndustryWireless Telecommunication Services
Earnings (Last)02-06
Earnings (Next)07-22
Inst Owners5.62%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.33B
Revenue(TTM)2.93B
Net Income(TTM)37.35M
Analysts46.67
Price Target19.89 (0.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.31%
PT rev (3m)-3.31%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)228.13%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-9.12%
Revenue NY rev (3m)-9.12%
Valuation
Industry RankSector Rank
PE 30.46
Fwd PE 94.69
P/S 0.67
P/FCF 15.18
P/OCF 2.82
P/B 1.39
P/tB N/A
EV/EBITDA 5.45
EPS(TTM)0.65
EY3.28%
EPS(NY)0.21
Fwd EY1.06%
FCF(TTM)1.3
FCFY6.59%
OCF(TTM)7.01
OCFY35.42%
SpS29.36
BVpS14.28
TBVpS-9.25
PEG (NY)N/A
PEG (5Y)N/A
Graham Number14.45
Profitability
Industry RankSector Rank
ROA 0.93%
ROE 3.88%
ROCE 4.85%
ROIC 3.64%
ROICexc 3.7%
ROICexgc 7.68%
OM 7.62%
PM (TTM) 1.89%
GM 68.11%
FCFM 4.44%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-5.83%
OM growth 5Y6.31%
PM growth 3Y-20.46%
PM growth 5Y-12.52%
GM growth 3Y4.66%
GM growth 5Y2.94%
F-Score7
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity 1.92
Debt/FCF 23.91
Debt/EBITDA 2.97
Cap/Depr 81.82%
Cap/Sales 19.45%
Interest Coverage 1.49
Cash Conversion 76.13%
Profit Quality 235.44%
Current Ratio 0.49
Quick Ratio 0.46
Altman-Z 0.97
F-Score7
WACC7.22%
ROIC/WACC0.5
Cap/Depr(3y)97.26%
Cap/Depr(5y)123.66%
Cap/Sales(3y)22.67%
Cap/Sales(5y)28.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75.72%
EPS 3Y-14.2%
EPS 5Y-7.42%
EPS Q2Q%9.76%
EPS Next Y-56.38%
EPS Next 2Y-47.41%
EPS Next 3Y-24.56%
EPS Next 5Y-10.95%
Revenue 1Y (TTM)46.76%
Revenue growth 3Y12.17%
Revenue growth 5Y8.35%
Sales Q2Q%93.22%
Revenue Next Year1.24%
Revenue Next 2Y0.75%
Revenue Next 3Y3.52%
Revenue Next 5Y2.71%
EBIT growth 1Y12.37%
EBIT growth 3Y5.63%
EBIT growth 5Y15.18%
EBIT Next Year211.78%
EBIT Next 3Y46.25%
EBIT Next 5Y31.78%
FCF growth 1Y125.99%
FCF growth 3YN/A
FCF growth 5Y-2.82%
OCF growth 1Y-1.29%
OCF growth 3Y10.51%
OCF growth 5Y8.82%

ORANGE BELGIUM / OBEL.BR FAQ

Can you provide the ChartMill fundamental rating for ORANGE BELGIUM?

ChartMill assigns a fundamental rating of 3 / 10 to OBEL.BR.


Can you provide the valuation status for ORANGE BELGIUM?

ChartMill assigns a valuation rating of 3 / 10 to ORANGE BELGIUM (OBEL.BR). This can be considered as Overvalued.


How profitable is ORANGE BELGIUM (OBEL.BR) stock?

ORANGE BELGIUM (OBEL.BR) has a profitability rating of 6 / 10.


How financially healthy is ORANGE BELGIUM?

The financial health rating of ORANGE BELGIUM (OBEL.BR) is 0 / 10.


What is the earnings growth outlook for ORANGE BELGIUM?

The Earnings per Share (EPS) of ORANGE BELGIUM (OBEL.BR) is expected to decline by -56.38% in the next year.